What is the generic name?

PALBOCICLIB

What is the Trade Name for PALBOCICLIB?

Ibrance

What are the Indications for PALBOCICLIB?

• 1 INDICATIONS AND USAGE IBRANCE is indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with: an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women or in men; or fulvestrant in patients with disease progression following endocrine therapy. IBRANCE is a kinase inhibitor indicated for the treatment of adult patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer in combination with: an aromatase inhibitor as initial endocrine-based therapy in postmenopausal women or in men ( 1) ; or fulvestrant in patients with disease progression following endocrine therapy. ( 1 )

References: https://open.fda.gov/